Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders.

World J Transplant · 2019 · PMC6682495 · PMID 31392129

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among the URD recipients, the use of serotherapy resulted in an estimated 5-year event-free survival (EFS) of 71% compared to 38% in the non-serotherapy group, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.